ArticleBlood advances2021

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML.

Brian C Shaffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.